The synthetic cannabinoid WIN55,212-2 mesylate (WIN) demonstrated sturdy anti-inflammatory results in monocytes and synovial fibroblasts only in large concentrations within a non-cannabinoid receptor dependent method. In this particular analyze we assessed the flexibility of WIN to modulate cytokine and MMP-three generation in SFs in excess of a large concentration variety https://billx863ntw6.mdkblog.com/profile